Related Experiment Video
Updated: May 15, 2026

06:26
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Subpocket analysis method for fragment-based drug discovery
Tuomo Kalliokoski1, Tjelvar S G Olsson, Anna Vulpetti
1Novartis Institutes for Biomedical Research, Postfach, CH-4002 Basel, Switzerland.
Journal of Chemical Information and Modeling
|January 19, 2013
Summary
Shared subpockets enable fragment-based drug design. A new computational method, SubCav, effectively identifies and aligns these subpockets, aiding in the discovery of new drug fragments and improving compound selectivity.
Area of Science:
- Computational chemistry
- Structural biology
- Drug discovery
Background:
- Binding sites can share similar subpockets despite overall dissimilarity.
- Information on shared subpockets is valuable for fragment-based drug design (FBDD).
- Existing FBDD methods may not efficiently identify or align these crucial subpockets.
Purpose of the Study:
- To introduce SubCav, a novel computational method for subpocket similarity searching and alignment.
- To enable the identification of shared subpockets across diverse protein structures.
- To facilitate the suggestion of new fragments and optimization of existing compounds in drug design.
Main Methods:
- Development of SubCav, a method utilizing pharmacophoric fingerprints.
- Implementation of a subpocket alignment algorithm within SubCav.
- Application of SubCav to a Protein Data Bank (PDB)-wide database for similarity searching.
Main Results:
- SubCav effectively aligns subpockets even with low sequence similarity.
- The method successfully retrieves relevant subpockets from large, diverse structural databases.
- SubCav demonstrates utility in analyzing subpockets within protein families.
Conclusions:
- SubCav is an effective tool for identifying shared subpockets, crucial for fragment-based drug design.
- The method aids in suggesting novel fragments and rationalizing compound selectivity.
- SubCav enhances the capabilities of drug discovery by leveraging structural information of binding sites.
Related Concept Videos
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

